Cinctive Capital Management LP Nevro Corp Transaction History

Cinctive Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $773,027 - $1.01 Million	19,012 Added 63.37%	49,012 $2.28 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $3.51 Million - $6.67 Million	-85,874 Reduced 74.11%	30,000 $1.32 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $4.1 Million - $6.3 Million	68,417 Added 144.17%	115,874 $8.38 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $1.19 Million - $1.78 Million	14,671 Added 44.75%	47,457 $3.85 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $3.34 Million - $5.45 Million	32,786 New	32,786 $3.82 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $1.23 Million - $1.56 Million	-10,750 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $961,587 - $1.4 Million	10,750 New	10,750 $1.28 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $1.07 Million - $2.2 Million	-15,225 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $1.16 Million - $1.79 Million	15,225 New	15,225 $1.79 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.